logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
4/3/2020 1:00:25 AM Regeneron And Sanofi Announce Detailed Positive Results From Pivotal Phase 3 Trial Evaluating Dupixent
3/30/2020 1:00:57 AM Regeneron, Sanofi: First Patient Outside Of US Treated As Part Of Global Clinical Program On Kevzara For Severe COVID-19
3/17/2020 7:02:20 AM Regeneron Reports Advances In Novel COVID-19 Antibody Program; Identifies Hundreds Of Virus-neutralizing Antibodies
3/16/2020 8:10:08 AM Sanofi And Regeneron Start Clinical Program Evaluating Kevzara For Severe COVID-19
2/27/2020 8:36:23 AM Fighting The Deadly Coronavirus
2/27/2020 7:38:15 AM Repligen Appoints Rohin Mhatre To Board
  
 
>